XTL Biopharmaceuticals LTD
SEC CIK 1023549 · XTLB · last insider filing 2026-03-23
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Hillel Fain Osnat | Director | filed 2026 - 2026 |
| Zuerblis Kenneth J | Director | filed 2008 - 2008 |
| Weiss Michael S | Director | filed 2008 - 2008 |
| Good Jennifer L | Director | filed 2008 - 2008 |
| Weiner BEN-Zion | Director | filed 2008 - 2008 |
| Rudman Samuel | Director | filed 2008 - 2008 |
| Kennedy William James | Director | filed 2008 - 2008 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Kessler William | Director of Finance | filed 2007 - 2007 |
| Bentsur RON | CEO | filed 2006 - 2007 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.